Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Intraparenchymal extravasation of gadolinium mimicking an enhancing brain tumor.

Ritchie DJ, Li CQ, Hoshide R, Vinocur D.

Neuroradiol J. 2019 Aug;32(4):273-276. doi: 10.1177/1971400919853789. Epub 2019 May 24.

PMID:
31124756
2.

Intraductal papillary mucinous neoplasm of the biliary tract: A precursor lesion to cholangiocarcinoma.

Ritchie DJ, Okamoto K, White SL.

Radiol Case Rep. 2019 Feb 13;14(4):495-500. doi: 10.1016/j.radcr.2019.01.023. eCollection 2019 Apr.

3.

Outcomes Associated With De-escalating Therapy for Methicillin-Resistant Staphylococcus aureus in Culture-Negative Nosocomial Pneumonia.

Cowley MC, Ritchie DJ, Hampton N, Kollef MH, Micek ST.

Chest. 2019 Jan;155(1):53-59. doi: 10.1016/j.chest.2018.10.014. Epub 2018 Oct 25.

PMID:
30621854
4.

Clinical epidemiology of carbapenem-resistant gram-negative sepsis among hospitalized patients: Shifting burden of disease?

Britt NS, Ritchie DJ, Kollef MH, Burnham CD, Durkin MJ, Hampton NB, Micek ST.

Am J Infect Control. 2018 Oct;46(10):1092-1096. doi: 10.1016/j.ajic.2018.03.013. Epub 2018 Apr 26.

5.

Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis.

Britt NS, Ritchie DJ, Kollef MH, Burnham CA, Durkin MJ, Hampton NB, Micek ST.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e02400-17. doi: 10.1128/AAC.02400-17. Print 2018 Apr.

6.

Telavancin for refractory MRSA bacteraemia in intermittent haemodialysis recipients.

Britt NS, Tirmizi S, Ritchie DJ, Topal JE, McManus D, Nizet V, Casabar E, Sakoulas G.

J Antimicrob Chemother. 2018 Mar 1;73(3):764-767. doi: 10.1093/jac/dkx437.

7.

Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria.

Gonzalez MD, McMullen AR, Wallace MA, Crotty MP, Ritchie DJ, Burnham CA.

Ann Lab Med. 2017 Mar;37(2):174-176. doi: 10.3343/alm.2017.37.2.174. No abstract available.

8.

Effective Antibiotic Conservation by Emergency Antimicrobial Stewardship During a Drug Shortage.

Hsueh K, Reyes M, Krekel T, Casabar E, Ritchie DJ, Jafarzadeh SR, Hays AJ, Lane MA, Durkin MJ.

Infect Control Hosp Epidemiol. 2017 Mar;38(3):356-359. doi: 10.1017/ice.2016.289. Epub 2016 Dec 5.

PMID:
27917734
9.

New Gram-Positive Agents: the Next Generation of Oxazolidinones and Lipoglycopeptides.

Crotty MP, Krekel T, Burnham CA, Ritchie DJ.

J Clin Microbiol. 2016 Sep;54(9):2225-32. doi: 10.1128/JCM.03395-15. Epub 2016 Mar 9. Review.

10.

Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults: An Observational Cohort Study.

Crotty MP, Meyers S, Hampton N, Bledsoe S, Ritchie DJ, Buller RS, Storch GA, Micek ST, Kollef MH.

Medicine (Baltimore). 2015 Dec;94(50):e2332. doi: 10.1097/MD.0000000000002332.

11.

Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship.

Crotty MP, Meyers S, Hampton N, Bledsoe S, Ritchie DJ, Buller RS, Storch GA, Kollef MH, Micek ST.

Crit Care. 2015 Nov 18;19:404. doi: 10.1186/s13054-015-1120-5.

12.

A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections.

Ritchie DJ, Garavaglia-Wilson A.

Clin Infect Dis. 2014 Dec 1;59 Suppl 6:S374-80. doi: 10.1093/cid/ciu613. Review.

PMID:
25371513
13.
14.

Health services management development: what formal knowledge should support the skills and experience required?

Ritchie DJ, Yen ML.

Aust Health Rev. 2013 May;37(2):189-93. doi: 10.1071/AH11116.

PMID:
23498856
15.

Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort.

Alexander BT, Marschall J, Tibbetts RJ, Neuner EA, Dunne WM Jr, Ritchie DJ.

Clin Ther. 2012 Jun;34(6):1314-23. doi: 10.1016/j.clinthera.2012.05.002. Erratum in: Clin Ther. 2012 Aug;34(8):1844.

16.

Acute renal insufficiency during telavancin therapy in clinical practice.

Marcos LA, Camins BC, Ritchie DJ, Casabar E, Warren DK.

J Antimicrob Chemother. 2012 Mar;67(3):723-6. doi: 10.1093/jac/dkr518. Epub 2011 Dec 15.

PMID:
22174040
17.

Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort study.

Crank CW, Scheetz MH, Brielmaier B, Rose WE, Patel GP, Ritchie DJ, Segreti J.

Clin Ther. 2010 Sep;32(10):1713-9. doi: 10.1016/j.clinthera.2010.09.008.

PMID:
21194593
18.

Vancomycin-associated leukocytoclastic vasculitis.

Pongruangporn M, Ritchie DJ, Lu D, Marschall J.

Case Rep Infect Dis. 2011;2011:356370. doi: 10.1155/2011/356370. Epub 2011 Jun 30.

19.

Use of cytomegalovirus intravenous immune globulin for the adjunctive treatment of cytomegalovirus in hematopoietic stem cell transplant recipients.

Alexander BT, Hladnik LM, Augustin KM, Casabar E, McKinnon PS, Reichley RM, Ritchie DJ, Westervelt P, Dubberke ER.

Pharmacotherapy. 2010 Jun;30(6):554-61. doi: 10.1592/phco.30.6.554.

20.

New antimicrobial agents for use in the intensive care unit.

Ritchie DJ, Alexander BT, Finnegan PM.

Infect Dis Clin North Am. 2009 Sep;23(3):665-81. doi: 10.1016/j.idc.2009.04.010. Review.

PMID:
19665089
21.

Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.

Arnold HM, McKinnon PS, Augustin KM, Hladnik LM, Casabar E, Reichley RM, Dubberke ER, Westervelt P, Ritchie DJ.

Pharmacotherapy. 2009 Aug;29(8):914-23. doi: 10.1592/phco.29.8.914.

23.

New antibiotics for healthcare-associated pneumonia.

Neuner EA, Ritchie DJ, Micek ST.

Semin Respir Crit Care Med. 2009 Feb;30(1):92-101. doi: 10.1055/s-0028-1119813. Epub 2009 Feb 6. Review.

PMID:
19199191
24.

Early clinical experience with anidulafungin at a large tertiary care medical center.

Brielmaier BD, Casabar E, Kurtzeborn CM, McKinnon PS, Ritchie DJ.

Pharmacotherapy. 2008 Jan;28(1):64-73.

PMID:
18154476
25.

Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae.

Daly MW, Riddle DJ, Ledeboer NA, Dunne WM, Ritchie DJ.

Pharmacotherapy. 2007 Jul;27(7):1052-7.

PMID:
17594211
26.

Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.

Deal EN, Micek ST, Ritchie DJ, Reichley RM, Dunne WM Jr, Kollef MH.

Pharmacotherapy. 2007 Feb;27(2):191-9.

PMID:
17253909
27.

Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.

Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie DJ, Micek ST, Kollef MH.

Chest. 2006 Oct;130(4):947-55.

PMID:
17035423
28.

A retrospective Evaluation of fluconazole for the treatment of Candida glabrata fungemia.

Wilson AG, Micek ST, Ritchie DJ.

Clin Ther. 2005 Aug;27(8):1228-37.

PMID:
16199247
29.

Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment.

Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH.

Antimicrob Agents Chemother. 2005 Apr;49(4):1306-11.

30.

Enterococcus faecalis resistant to linezolid: case series and review of the literature.

Burleson BS, Ritchie DJ, Micek ST, Dunne WM.

Pharmacotherapy. 2004 Sep;24(9):1225-31. Review.

PMID:
15460184
31.

Adefovir dipivoxil: a new antiviral agent for the treatment of hepatitis B virus infection.

Qaqish RB, Mattes KA, Ritchie DJ.

Clin Ther. 2003 Dec;25(12):3084-99. Review.

PMID:
14749147
32.

Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

Zervos MJ, Hershberger E, Nicolau DP, Ritchie DJ, Blackner LK, Coyle EA, Donnelly AJ, Eckel SF, Eng RH, Hiltz A, Kuyumjian AG, Krebs W, McDaniel A, Hogan P, Lubowski TJ.

Clin Infect Dis. 2003 Dec 15;37(12):1643-8. Epub 2003 Nov 20.

PMID:
14689346
33.

Enterobacter cloacae ventriculitis successfully treated with cefepime and gentamicin: case report and review of the literature.

Barnes BJ, Wiederhold NP, Micek ST, Polish LB, Ritchie DJ.

Pharmacotherapy. 2003 Apr;23(4):537-42. Review.

PMID:
12680484
34.

Rhinocerebral mucormycosis in the era of lipid-based amphotericin B: case report and literature review.

Mondy KE, Haughey B, Custer PL, Wippold FJ 2nd, Ritchie DJ, Mundy LM.

Pharmacotherapy. 2002 Apr;22(4):519-26. Review.

PMID:
11939688
35.

Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid.

Babcock HM, Ritchie DJ, Christiansen E, Starlin R, Little R, Stanley S.

Clin Infect Dis. 2001 May 1;32(9):1373-5. Epub 2001 Apr 9.

PMID:
11303275
36.

A prospective, randomized trial to assess the cost impact of pharmacist-initiated interventions.

McMullin ST, Hennenfent JA, Ritchie DJ, Huey WY, Lonergan TP, Schaiff RA, Tonn ME, Bailey TC.

Arch Intern Med. 1999 Oct 25;159(19):2306-9.

PMID:
10547170
37.

A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutions.

Bailey TC, Ritchie DJ, McMullin ST, Kahn M, Reichley RM, Casabar E, Shannon W, Dunagan WC.

Pharmacotherapy. 1997 Mar-Apr;17(2):277-81.

PMID:
9085319
38.
39.

Stability of octreotide acetate in polypropylene syringes at 5 and -20 degrees C.

Ripley RG, Ritchie DJ, Holstad SG.

Am J Health Syst Pharm. 1995 Sep 1;52(17):1910-1. No abstract available.

PMID:
8528855
40.
41.

Intraocular injection of ceftazidime. Effects of inflammation and surgery.

Shaarawy A, Meredith TA, Kincaid M, Dick J, Aguilar E, Ritchie DJ, Reichley RM.

Retina. 1995;15(5):433-8.

PMID:
8594638
42.

Vancomycin levels after intravitreal injection. Effects of inflammation and surgery.

Aguilar HE, Meredith TA, el-Massry A, Shaarawy A, Kincaid M, Dick J, Ritchie DJ, Reichley RM, Neisman MK.

Retina. 1995;15(5):428-32.

PMID:
8594637
43.

Update on the management of intestinal cryptosporidiosis in AIDS.

Ritchie DJ, Becker ES.

Ann Pharmacother. 1994 Jun;28(6):767-78. Review.

PMID:
7919569
44.

Evaluation and financial impact of imipenem/cilastatin dosing in elderly patients based on renal function and body weight.

Ritchie DJ, Reichley RM, Canaday KL, Bailey TC.

J Pharm Technol. 1993 Jul-Aug;9(4):160-3.

PMID:
10128045
45.

Use of paromomycin for treatment of cryptosporidiosis in patients with AIDS.

Fichtenbaum CJ, Ritchie DJ, Powderly WG.

Clin Infect Dis. 1993 Feb;16(2):298-300.

PMID:
8443313
46.

In vitro activity of clarithromycin, cefprozil, and other common oral antimicrobial agents against gram-positive and gram-negative pathogens.

Ritchie DJ, Hopefl AW, Milligan TW, Byrne JE, Maddux MS.

Clin Ther. 1993 Jan-Feb;15(1):107-13.

PMID:
8458040
47.

Acceptance of a pharmacy-based, physician-edited hospital pharmacy and therapeutics committee newsletter.

Ritchie DJ, Manchester RF, Rich MW, Rockwell MM, Stein PM.

Ann Pharmacother. 1992 Jul-Aug;26(7-8):886-9.

PMID:
1504393
48.

Activity of octreotide acetate in a total nutrient admixture.

Ritchie DJ, Holstad SG, Westrich TJ, Hirsch JD, O'Dorisio TM.

Am J Hosp Pharm. 1991 Oct;48(10):2172-5. Erratum in: Am J Hosp Pharm 1991 Nov;48(11):2384.

PMID:
1781474
49.

Comment: consideration of amphotericin B hepatotoxicity.

Ritchie DJ.

DICP. 1991 May;25(5):559-60. No abstract available.

PMID:
2068844
50.

Diltiazem-induced psychosis and a possible diltiazem-lithium interaction.

Binder EF, Cayabyab L, Ritchie DJ, Birge SJ.

Arch Intern Med. 1991 Feb;151(2):373-4.

PMID:
1899553

Supplemental Content

Loading ...
Support Center